Loading…

Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation

Background: Several factors influence clinical outcome after autologous chondrocyte implantation (ACI) for the treatment of cartilage defects of the knee joint. Hypothesis/Purpose: The aim of the present study was to investigate the influence of cell quality on clinical outcome after ACI. The hypoth...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of sports medicine 2012-03, Vol.40 (3), p.556-561
Main Authors: Niemeyer, Philipp, Pestka, Jan M., Salzmann, Gian M., Südkamp, Norbert P., Schmal, Hagen
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03
cites cdi_FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03
container_end_page 561
container_issue 3
container_start_page 556
container_title The American journal of sports medicine
container_volume 40
creator Niemeyer, Philipp
Pestka, Jan M.
Salzmann, Gian M.
Südkamp, Norbert P.
Schmal, Hagen
description Background: Several factors influence clinical outcome after autologous chondrocyte implantation (ACI) for the treatment of cartilage defects of the knee joint. Hypothesis/Purpose: The aim of the present study was to investigate the influence of cell quality on clinical outcome after ACI. The hypothesis of the authors was that cell quality at the time of transplantation influences clinical outcome after ACI for cartilage defects. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 80 patients were included in the present study. Knee function was assessed before surgery as well as 6, 12, and 24 months after ACI using standard instruments (International Knee Documentation Committee [IKDC], Lysholm, and Tegner scores). Cell quality was evaluated by determination of antigen expression of CD44 expression, aggrecan, collagen type II, and cell viability. A linear regression analysis including preoperative knee function, defect size, defect location, defect origin, body mass index, patient age, and other parameters was performed to evaluate the influence of these parameters on postoperative knee function. Results: Preoperative IKDC score increased from 49.6 ± 13.8 points to 75.5 ± 14.6 points at 24 months (P < .05). Postoperative IKDC score at 6, 12, and 24 months was significantly influenced by collagen type II expression, CD44 expression, and cell viability (all P < .05). No correlation between aggrecan and outcome was found. Quantitative influence of individual factors differed between different time points. Conclusion: Cell quality seems to be one of many factors that influences clinical outcome after ACI in patients with cartilage defects of the knee joint. It constitutes one aspect among various others affecting clinical outcome.
doi_str_mv 10.1177/0363546511428879
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_954661366</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0363546511428879</sage_id><sourcerecordid>926646515</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03</originalsourceid><addsrcrecordid>eNqFkc1r3DAQxUVpaTZp7z0VUSg5udGHJdnHxTTpQiAUAjkaWR6lDrK0leTD_veR2W0DgdLTHOY3b-bNQ-gTJd8oVeqKcMlFLQWlNWsa1b5BGyoEqziX4i3arO1q7Z-h85SeCCFUyeY9OmOMqprXbIMedt66BbwBHCzuwDn8c9FuygccPO7c5CejHb5bsgkz4K3NEPF2ycGFx7Ak3P0KfozBHDLg3bx32medp-A_oHdWuwQfT_UC3V9_v-9-VLd3N7tue1uZmolcWcKYGNTIbCtboSyrQbcDEwwGY4Rom9EyPmo1aM0bAWMjarC2oTUFsCPhF-jyKLuP4fcCKffzlExxoT2U8_q2uJeUS_l_kkm5flIU8ssr8iks0RcXBVKUNbRdIXKETAwpRbD9Pk6zjoeekn7Npn-dTRn5fNJdhhnGvwN_wijA1xOgU3m6jdqbKb1wQrGitQpVRy7pR3g57p-LnwFn8KLI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>927128195</pqid></control><display><type>article</type><title>Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation</title><source>EBSCOhost SPORTDiscus with Full Text</source><source>SAGE</source><creator>Niemeyer, Philipp ; Pestka, Jan M. ; Salzmann, Gian M. ; Südkamp, Norbert P. ; Schmal, Hagen</creator><creatorcontrib>Niemeyer, Philipp ; Pestka, Jan M. ; Salzmann, Gian M. ; Südkamp, Norbert P. ; Schmal, Hagen</creatorcontrib><description>Background: Several factors influence clinical outcome after autologous chondrocyte implantation (ACI) for the treatment of cartilage defects of the knee joint. Hypothesis/Purpose: The aim of the present study was to investigate the influence of cell quality on clinical outcome after ACI. The hypothesis of the authors was that cell quality at the time of transplantation influences clinical outcome after ACI for cartilage defects. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 80 patients were included in the present study. Knee function was assessed before surgery as well as 6, 12, and 24 months after ACI using standard instruments (International Knee Documentation Committee [IKDC], Lysholm, and Tegner scores). Cell quality was evaluated by determination of antigen expression of CD44 expression, aggrecan, collagen type II, and cell viability. A linear regression analysis including preoperative knee function, defect size, defect location, defect origin, body mass index, patient age, and other parameters was performed to evaluate the influence of these parameters on postoperative knee function. Results: Preoperative IKDC score increased from 49.6 ± 13.8 points to 75.5 ± 14.6 points at 24 months (P &lt; .05). Postoperative IKDC score at 6, 12, and 24 months was significantly influenced by collagen type II expression, CD44 expression, and cell viability (all P &lt; .05). No correlation between aggrecan and outcome was found. Quantitative influence of individual factors differed between different time points. Conclusion: Cell quality seems to be one of many factors that influences clinical outcome after ACI in patients with cartilage defects of the knee joint. It constitutes one aspect among various others affecting clinical outcome.</description><identifier>ISSN: 0363-5465</identifier><identifier>EISSN: 1552-3365</identifier><identifier>DOI: 10.1177/0363546511428879</identifier><identifier>PMID: 22174342</identifier><identifier>CODEN: AJSMDO</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Adolescent ; Adult ; Aggrecans - biosynthesis ; Biological and medical sciences ; Cartilage ; Cartilage, Articular - injuries ; Cartilage, Articular - surgery ; Cell Survival - physiology ; Cells ; Chondrocytes - transplantation ; Clinical outcomes ; Collagen ; Collagen Type II - biosynthesis ; Diseases of the osteoarticular system ; Female ; Humans ; Hyaluronan Receptors - biosynthesis ; Knee ; Knee - physiopathology ; Knee - surgery ; Male ; Medical sciences ; Orthopedic surgery ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Transplantation, Autologous ; Transplants &amp; implants ; Treatment Outcome ; Young Adult</subject><ispartof>The American journal of sports medicine, 2012-03, Vol.40 (3), p.556-561</ispartof><rights>2012 American Orthopaedic Society for Sports Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright Sage Publications Ltd. Mar 2012</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03</citedby><cites>FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25721429$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22174342$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niemeyer, Philipp</creatorcontrib><creatorcontrib>Pestka, Jan M.</creatorcontrib><creatorcontrib>Salzmann, Gian M.</creatorcontrib><creatorcontrib>Südkamp, Norbert P.</creatorcontrib><creatorcontrib>Schmal, Hagen</creatorcontrib><title>Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation</title><title>The American journal of sports medicine</title><addtitle>Am J Sports Med</addtitle><description>Background: Several factors influence clinical outcome after autologous chondrocyte implantation (ACI) for the treatment of cartilage defects of the knee joint. Hypothesis/Purpose: The aim of the present study was to investigate the influence of cell quality on clinical outcome after ACI. The hypothesis of the authors was that cell quality at the time of transplantation influences clinical outcome after ACI for cartilage defects. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 80 patients were included in the present study. Knee function was assessed before surgery as well as 6, 12, and 24 months after ACI using standard instruments (International Knee Documentation Committee [IKDC], Lysholm, and Tegner scores). Cell quality was evaluated by determination of antigen expression of CD44 expression, aggrecan, collagen type II, and cell viability. A linear regression analysis including preoperative knee function, defect size, defect location, defect origin, body mass index, patient age, and other parameters was performed to evaluate the influence of these parameters on postoperative knee function. Results: Preoperative IKDC score increased from 49.6 ± 13.8 points to 75.5 ± 14.6 points at 24 months (P &lt; .05). Postoperative IKDC score at 6, 12, and 24 months was significantly influenced by collagen type II expression, CD44 expression, and cell viability (all P &lt; .05). No correlation between aggrecan and outcome was found. Quantitative influence of individual factors differed between different time points. Conclusion: Cell quality seems to be one of many factors that influences clinical outcome after ACI in patients with cartilage defects of the knee joint. It constitutes one aspect among various others affecting clinical outcome.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aggrecans - biosynthesis</subject><subject>Biological and medical sciences</subject><subject>Cartilage</subject><subject>Cartilage, Articular - injuries</subject><subject>Cartilage, Articular - surgery</subject><subject>Cell Survival - physiology</subject><subject>Cells</subject><subject>Chondrocytes - transplantation</subject><subject>Clinical outcomes</subject><subject>Collagen</subject><subject>Collagen Type II - biosynthesis</subject><subject>Diseases of the osteoarticular system</subject><subject>Female</subject><subject>Humans</subject><subject>Hyaluronan Receptors - biosynthesis</subject><subject>Knee</subject><subject>Knee - physiopathology</subject><subject>Knee - surgery</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Orthopedic surgery</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Transplantation, Autologous</subject><subject>Transplants &amp; implants</subject><subject>Treatment Outcome</subject><subject>Young Adult</subject><issn>0363-5465</issn><issn>1552-3365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNqFkc1r3DAQxUVpaTZp7z0VUSg5udGHJdnHxTTpQiAUAjkaWR6lDrK0leTD_veR2W0DgdLTHOY3b-bNQ-gTJd8oVeqKcMlFLQWlNWsa1b5BGyoEqziX4i3arO1q7Z-h85SeCCFUyeY9OmOMqprXbIMedt66BbwBHCzuwDn8c9FuygccPO7c5CejHb5bsgkz4K3NEPF2ycGFx7Ak3P0KfozBHDLg3bx32medp-A_oHdWuwQfT_UC3V9_v-9-VLd3N7tue1uZmolcWcKYGNTIbCtboSyrQbcDEwwGY4Rom9EyPmo1aM0bAWMjarC2oTUFsCPhF-jyKLuP4fcCKffzlExxoT2U8_q2uJeUS_l_kkm5flIU8ssr8iks0RcXBVKUNbRdIXKETAwpRbD9Pk6zjoeekn7Npn-dTRn5fNJdhhnGvwN_wijA1xOgU3m6jdqbKb1wQrGitQpVRy7pR3g57p-LnwFn8KLI</recordid><startdate>20120301</startdate><enddate>20120301</enddate><creator>Niemeyer, Philipp</creator><creator>Pestka, Jan M.</creator><creator>Salzmann, Gian M.</creator><creator>Südkamp, Norbert P.</creator><creator>Schmal, Hagen</creator><general>SAGE Publications</general><general>Sage Publications</general><general>Sage Publications Ltd</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TS</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>U9A</scope><scope>7X8</scope></search><sort><creationdate>20120301</creationdate><title>Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation</title><author>Niemeyer, Philipp ; Pestka, Jan M. ; Salzmann, Gian M. ; Südkamp, Norbert P. ; Schmal, Hagen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aggrecans - biosynthesis</topic><topic>Biological and medical sciences</topic><topic>Cartilage</topic><topic>Cartilage, Articular - injuries</topic><topic>Cartilage, Articular - surgery</topic><topic>Cell Survival - physiology</topic><topic>Cells</topic><topic>Chondrocytes - transplantation</topic><topic>Clinical outcomes</topic><topic>Collagen</topic><topic>Collagen Type II - biosynthesis</topic><topic>Diseases of the osteoarticular system</topic><topic>Female</topic><topic>Humans</topic><topic>Hyaluronan Receptors - biosynthesis</topic><topic>Knee</topic><topic>Knee - physiopathology</topic><topic>Knee - surgery</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Orthopedic surgery</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Transplantation, Autologous</topic><topic>Transplants &amp; implants</topic><topic>Treatment Outcome</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niemeyer, Philipp</creatorcontrib><creatorcontrib>Pestka, Jan M.</creatorcontrib><creatorcontrib>Salzmann, Gian M.</creatorcontrib><creatorcontrib>Südkamp, Norbert P.</creatorcontrib><creatorcontrib>Schmal, Hagen</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Physical Education Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of sports medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niemeyer, Philipp</au><au>Pestka, Jan M.</au><au>Salzmann, Gian M.</au><au>Südkamp, Norbert P.</au><au>Schmal, Hagen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation</atitle><jtitle>The American journal of sports medicine</jtitle><addtitle>Am J Sports Med</addtitle><date>2012-03-01</date><risdate>2012</risdate><volume>40</volume><issue>3</issue><spage>556</spage><epage>561</epage><pages>556-561</pages><issn>0363-5465</issn><eissn>1552-3365</eissn><coden>AJSMDO</coden><abstract>Background: Several factors influence clinical outcome after autologous chondrocyte implantation (ACI) for the treatment of cartilage defects of the knee joint. Hypothesis/Purpose: The aim of the present study was to investigate the influence of cell quality on clinical outcome after ACI. The hypothesis of the authors was that cell quality at the time of transplantation influences clinical outcome after ACI for cartilage defects. Study Design: Cohort study; Level of evidence, 3. Methods: A total of 80 patients were included in the present study. Knee function was assessed before surgery as well as 6, 12, and 24 months after ACI using standard instruments (International Knee Documentation Committee [IKDC], Lysholm, and Tegner scores). Cell quality was evaluated by determination of antigen expression of CD44 expression, aggrecan, collagen type II, and cell viability. A linear regression analysis including preoperative knee function, defect size, defect location, defect origin, body mass index, patient age, and other parameters was performed to evaluate the influence of these parameters on postoperative knee function. Results: Preoperative IKDC score increased from 49.6 ± 13.8 points to 75.5 ± 14.6 points at 24 months (P &lt; .05). Postoperative IKDC score at 6, 12, and 24 months was significantly influenced by collagen type II expression, CD44 expression, and cell viability (all P &lt; .05). No correlation between aggrecan and outcome was found. Quantitative influence of individual factors differed between different time points. Conclusion: Cell quality seems to be one of many factors that influences clinical outcome after ACI in patients with cartilage defects of the knee joint. It constitutes one aspect among various others affecting clinical outcome.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>22174342</pmid><doi>10.1177/0363546511428879</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-5465
ispartof The American journal of sports medicine, 2012-03, Vol.40 (3), p.556-561
issn 0363-5465
1552-3365
language eng
recordid cdi_proquest_miscellaneous_954661366
source EBSCOhost SPORTDiscus with Full Text; SAGE
subjects Adolescent
Adult
Aggrecans - biosynthesis
Biological and medical sciences
Cartilage
Cartilage, Articular - injuries
Cartilage, Articular - surgery
Cell Survival - physiology
Cells
Chondrocytes - transplantation
Clinical outcomes
Collagen
Collagen Type II - biosynthesis
Diseases of the osteoarticular system
Female
Humans
Hyaluronan Receptors - biosynthesis
Knee
Knee - physiopathology
Knee - surgery
Male
Medical sciences
Orthopedic surgery
Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases
Transplantation, Autologous
Transplants & implants
Treatment Outcome
Young Adult
title Influence of Cell Quality on Clinical Outcome After Autologous Chondrocyte Implantation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T13%3A40%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20Cell%20Quality%20on%20Clinical%20Outcome%20After%20Autologous%20Chondrocyte%20Implantation&rft.jtitle=The%20American%20journal%20of%20sports%20medicine&rft.au=Niemeyer,%20Philipp&rft.date=2012-03-01&rft.volume=40&rft.issue=3&rft.spage=556&rft.epage=561&rft.pages=556-561&rft.issn=0363-5465&rft.eissn=1552-3365&rft.coden=AJSMDO&rft_id=info:doi/10.1177/0363546511428879&rft_dat=%3Cproquest_cross%3E926646515%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c425t-f0225b7d2f96957f24ea9b252ebcc5598df23da7baa385ed854eff8141eefd03%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=927128195&rft_id=info:pmid/22174342&rft_sage_id=10.1177_0363546511428879&rfr_iscdi=true